Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Paul D Ziegler"'
Publikováno v:
PLoS ONE, Vol 17, Iss 6, p e0270398 (2022)
Diagnosing cardiac pauses that could produce syncopal episodes is important to guide appropriate therapy. However, the infrequent nature of these episodes can make detection challenging with conventional monitoring (CM) strategies with short-term ECG
Externí odkaz:
https://doaj.org/article/4559dcfdc52841de903341f021ebbdd9
Autor:
Mitchell S V Elkind, Claudia I Rinciog, Laura M Sawyer, Alexander Diamantopoulos, Matthew Reynolds, Stylianos I Tsintzos, Paul D Ziegler, Maria E Quiroz, Claudia Wolff, Klaus K Witte
Publikováno v:
Open Heart, Vol 6, Iss 1 (2019)
Objective To evaluate the cost-effectiveness of insertable cardiac monitors (ICMs) compared with standard of care (SoC) for detecting atrial fibrillation (AF) in patients at high risk of stroke (CHADS2 >2), using a UK National Health Service (NHS) pe
Externí odkaz:
https://doaj.org/article/90223183eaf74a51a0e5c5dd9b8226f4
Autor:
Yuichiro Yano, Philip Greenland, Donald M Lloyd-Jones, Emile G Daoud, Jodi L Koehler, Paul D Ziegler
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148914 (2016)
BACKGROUND:New technologies are diffusing into medical practice swiftly. Hand-held devices such as smartphones can record short-duration (e.g., 1-minute) ECGs, but their effectiveness in identifying patients with paroxysmal atrial fibrillation (AF) i
Externí odkaz:
https://doaj.org/article/7b45f12b82b8401d9d9572e9193f9f3b
Autor:
Efstratios I Charitos, Paul D Ziegler, Ulrich Stierle, Derek R Robinson, Bernhard Graf, Hans-Hinrich Sievers, Thorsten Hanke
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e89022 (2014)
Although atrial fibrillation (AF) recurrence is unpredictable in terms of onset and duration, current intermittent rhythm monitoring (IRM) diagnostic modalities are short-termed and discontinuous. The aim of the present study was to investigate the n
Externí odkaz:
https://doaj.org/article/7738dc612cba41aba14eaa92cd767c5a
Autor:
Rachel M. Kaplan, Paul D. Ziegler, Jodi Koehler, Sean Landman, Shantanu Sarkar, Rod S. Passman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 24 (2020)
Background Guideline recommendations for oral anticoagulation (OAC) in patients with atrial fibrillation (AF) are based on CHA2DS2‐VASc score alone. Patients with cardiac implantable electronic devices provide an opportunity to assess how the inter
Externí odkaz:
https://doaj.org/article/205bbea05f114933a80f81035ae0ada2
Publikováno v:
Heart Rhythm. 19:1405-1411
Impaired quality of life due to atrial fibrillation (AF), which often includes decreased activity level, is an indication for ablation. However, the impact of ablation for AF on activity is poorly understood.The purpose of this study was to assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cffd8fd79f62077fab6cc797701d143
https://doi.org/10.1016/j.hrthm.2022.06.013
https://doi.org/10.1016/j.hrthm.2022.06.013
Autor:
Shadi Yaghi, Michael P. Ryan, Candace L. Gunnarsson, William Irish, Sarah C. Rosemas, Karah Neisen, Paul D. Ziegler, Matthew R. Reynolds
Publikováno v:
Heart Rhythm O2. 3:223-230
Guidelines recommend a confirmed diagnosis of atrial fibrillation (AF) to initiate oral anticoagulation in cryptogenic stroke (CS) patients. However, the intermittent nature of AF can make detection challenging with intermittent short-term cardiac mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb59a3aa3d6eb5dcb6c976e7a069f51a
https://doi.org/10.1016/j.hroo.2022.02.006
https://doi.org/10.1016/j.hroo.2022.02.006
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 23 (2018)
Background Recent evidence shows an association between the level of physical activity and cardiovascular mortality and morbidity in patients with atrial fibrillation (AF). We sought to assess the impact of AF daily burden on the activity level of th
Externí odkaz:
https://doaj.org/article/a5c85e82a97642cba37b8924ac69b729
Autor:
Moussa C, Mansour, Emily M, Gillen, Audrey, Garman, Sarah C, Rosemas, Noreli, Franco, Paul D, Ziegler, Jesse M, Pines
Publikováno v:
Heart Rhythm O2. 3:79-90
Compared with short-term electrocardiogram (ECG) monitors, insertable cardiac monitors (ICMs) have been shown to increase atrial fibrillation (AF) detection rates and the opportunity to treat recurrent AF in patients postablation.To examine healthcar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a63a11282598db47458ee747bad488
https://doi.org/10.1016/j.hroo.2021.12.005
https://doi.org/10.1016/j.hroo.2021.12.005
Autor:
K K Witte, David Lanctin, Stelios I Tsintzos, L. Sawyer, Claudia Rinciog, Scott E. Kasner, Matthew R. Reynolds, Sarah C Rosemas, Mitchell Elkind, Paul D. Ziegler, Frank Jones
Publikováno v:
BMC Cardiovascular Disorders. 23
Background Insertable cardiac monitors (ICMs) are a clinically effective means of detecting atrial fibrillation (AF) in high-risk patients, and guiding the initiation of non-vitamin K oral anticoagulants (NOACs). Their cost-effectiveness from a US cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278aaf4f822e38588d583f5702e2055a
https://doi.org/10.1186/s12872-023-03073-6
https://doi.org/10.1186/s12872-023-03073-6